Alteration of the risk of pre-oral cancer and cancer in North Indian population by NAT1 and NAT2 polymorphisms genotypes and haplotypes

被引:2
|
作者
Nigam, Kumud [1 ,2 ]
Gupta, Shalini [2 ]
Gupta, Om Prakash [3 ]
Srivastav, Ratnesh Kumar [2 ]
Singh, Saurabh Pratap [2 ]
Sanyal, Somali [1 ]
机构
[1] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Lucknow Campus, Lucknow 226028, Uttar Pradesh, India
[2] King Georges Med Univ, Dept Oral Pathol & Microbiol, Lucknow 226003, Uttar Pradesh, India
[3] Career Med Coll, Lucknow, Uttar Pradesh, India
关键词
Oral cancer; Pre-oral cancer; N-acetyl transferases; PCR; RFLP; ARYLAMINE N-ACETYLTRANSFERASES; GENETIC POLYMORPHISMS; SUSCEPTIBILITY; CYP1A1; GSTM1; GSTT1; LOCI; CONSUMPTION; ALCOHOL; SMOKING;
D O I
10.1007/s00405-021-06774-w
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose The risk of oral cancer is strongly related to consumption of tobacco, smoking and drinking alcohol. N-acetyl transferases 1,2 are phase II metabolic enzymes, metabolize aryl and heterocyclic amines which are present in tobacco. NAT2 slows acetylator phenotype and the genotype is related to reduced ability to detoxify these xenobiotic that are carcinogenic to tissues. The aim of our study to determine the risk of oral cancer as well as oral precancerous lesions in North Indian population with polymorphisms in these two N-acetyl transferases 1,2 genes. Materials and methods A total of 250 patients with pre oral cancer, oral cancer and 250 healthy volunteers were genotypes for the NAT1 and NAT2 gene polymorphisms. Genotypes were identified by PCR and RFLP. Genotype frequencies were evaluated by Chi-square test and risk of disease was estimated by Odds ratio (OR) with 95% confidence interval. Result Our results showed that individuals with CT and TT genotypes of NAT1 C > T polymorphism were significantly lower risk of oral diseases (p value = 0.02, OR = 0.60 and p value = 0.04, OR = 0.58, respectively). For NAT2 C > T polymorphism, the TT genotype significantly increased the risk of OSMF (Oral Sub mucous Fibrosis) and Leukoplakia (p value = 0.001, OR = 4.16; p value = 0.002, OR = 4.38, respectively). In contrary, the CC genotype for NAT2 T > C polymorphism increased the risk of OSMF (p value = 0.01, OR = 3.00, 95% CI = 1.31-6.86). Conclusion Our study concludes that the NAT1 polymorphism shows protective association with oral diseases and NAT2 polymorphism and haplotypes also influence the susceptibility to oral diseases in North Indian population subjects.
引用
收藏
页码:4081 / 4089
页数:9
相关论文
共 50 条
  • [31] NAT2 and GSTM1 polymorphisms affect the risk of bladder cancer
    Alexandra King
    Nature Clinical Practice Oncology, 2005, 2 (11): : 540 - 540
  • [32] Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility
    Wikman, H
    Thiel, S
    Jäger, B
    Schmezer, P
    Spiegelhalder, B
    Edler, L
    Dienemann, H
    Kayser, K
    Schulz, V
    Drings, P
    Bartsch, H
    Risch, A
    PHARMACOGENETICS, 2001, 11 (02): : 157 - 168
  • [34] Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer
    Troy, Jesse D.
    Weissfeld, Joel L.
    Diergaarde, Brenda
    Youk, Ada O.
    Buch, Shama C.
    Romkes, Marjorie
    Grandis, Jennifer R.
    CANCER EPIDEMIOLOGY, 2013, 37 (04) : 505 - 511
  • [35] Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer
    Majumder, Mousumi
    Ghosh, Saurabh
    Roy, Bidyut
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 136 (04) : 605 - 613
  • [36] Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer
    M. V. Nikishina
    V. A. Vavilin
    S. I. Makarova
    V. V. Lyakhovich
    Bulletin of Experimental Biology and Medicine, 2007, 143 : 83 - 86
  • [37] Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer
    Nikishina, M. V.
    Vavilin, V. A.
    Makarova, S. I.
    Lyakhovich, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (01) : 83 - 86
  • [38] Polymorphisms in the N-acetyltransferase 1 (NAT1) gene and lung cancer risk in a minority population
    Ishibe, N
    Wiencke, JK
    Zuo, ZF
    McMillan, A
    Spitz, MR
    Kelsey, KT
    BIOMARKERS, 1998, 3 (03) : 219 - 226
  • [39] No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition
    Agudo, A
    Sala, N
    Pera, G
    Capellá, G
    Berenguer, A
    García, N
    Palli, D
    Boeing, H
    Del Giudice, G
    Saieva, C
    Carneiro, F
    Berrino, F
    Sacerdote, C
    Tumino, R
    Panico, S
    Berglund, G
    Simán, H
    Stenling, R
    Hallmans, G
    Martínez, C
    Amiano, P
    Barricarte, A
    Navarro, C
    Quirós, JR
    Allen, N
    Key, T
    Bingham, S
    Khaw, KT
    Linseisen, J
    Nagel, G
    Overvad, K
    Tjonneland, A
    Olsen, A
    Bueno-De-Mesquita, HB
    Boshuizen, HC
    Peeters, PH
    Numans, ME
    Clavel-Chapelon, F
    Boutron-Ruault, MC
    Trichopoulou, A
    Lund, E
    Bläker, H
    Jenab, M
    Ferrari, P
    Norat, T
    Riboli, E
    González, CA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (05) : 1043 - 1045
  • [40] The association of NAT2 polymorphisms with sporadic breast cancer
    Artamonov, VV
    Lyubchenko, LN
    Shabanov, MA
    Nemtsova, MV
    Zaletaev, DV
    MOLECULAR BIOLOGY, 2004, 38 (03) : 383 - 387